Kappa/Lambda Light Chain, ISH without Interpretation
Use
An atypical ratio of kappa to lambda expressing cells, or a non‑random distribution of these cells, is indicative of a possible neoplasia of the kappa or lambda expressing cells.
Special Instructions
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. Performing laboratory: Quest Diagnostics Nichols Institute.
Limitations
Not provided.
Methodology
Other
Biomarkers
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Unknown)
Volume
Not provided
Minimum Volume
Not provided
Container
IHC Specimen Transport Kit
Storage Instructions
Room temperature: indefinitely; Refrigerated: indefinitely; Frozen: unacceptable
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |